Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.70 | 22.67 | 21.31 | 21.50 | 20.26 | 20.46 | 21.20 | 22.64 | 23.52 | 21.84 | 19.72 | 18.99 |
| Expenses | 22.48 | 23.30 | 18.63 | 19.29 | 17.95 | 17.76 | 18.17 | 19.37 | 19.59 | 18.22 | 17.78 | 16.06 |
| Operating Profit | 1.22 | -0.63 | 2.68 | 2.21 | 2.31 | 2.70 | 3.03 | 3.27 | 3.93 | 3.62 | 1.94 | 2.93 |
| OPM % | 5.15% | -2.78% | 12.58% | 10.28% | 11.40% | 13.20% | 14.29% | 14.44% | 16.71% | 16.58% | 9.84% | 15.43% |
| Other Income | 0.22 | 3.13 | 0.68 | 0.14 | 0.18 | 0.53 | 0.49 | 0.86 | 0.42 | 0.50 | 0.29 | 0.23 |
| Interest | 1.31 | 1.44 | 1.76 | 1.51 | 1.50 | 1.89 | 1.56 | 1.44 | 1.40 | 1.66 | 1.66 | 1.50 |
| Depreciation | 1.59 | 1.45 | 1.43 | 1.48 | 1.51 | 1.69 | 1.68 | 1.66 | 1.64 | 1.62 | 1.52 | 1.46 |
| Profit before tax | -1.46 | -0.39 | 0.17 | -0.64 | -0.52 | -0.35 | 0.28 | 1.03 | 1.31 | 0.84 | -0.95 | 0.20 |
| Tax % | -25.34% | -48.72% | 5.88% | 6.25% | 7.69% | 57.14% | -28.57% | 11.65% | 23.66% | 30.95% | -258.95% | -130.00% |
| Net Profit | -1.10 | -0.20 | 0.15 | -0.69 | -0.55 | -0.54 | 0.36 | 0.91 | 1.00 | 0.59 | 1.52 | 0.46 |
| EPS in Rs | -1.07 | -0.20 | 0.15 | -0.67 | -0.54 | -0.53 | 0.35 | 0.89 | 0.98 | 0.58 | 1.48 | 0.45 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 108.48 | 91.33 | 80.88 | 70.02 | 90.62 | 119.16 | 110.49 | 90.19 | 83.42 | 87.72 | 84.07 |
| Expenses | 93.33 | 77.44 | 69.62 | 76.95 | 85.27 | 101.78 | 94.32 | 85.93 | 73.06 | 74.95 | 71.65 |
| Operating Profit | 15.15 | 13.89 | 11.26 | -6.93 | 5.35 | 17.38 | 16.17 | 4.26 | 10.36 | 12.77 | 12.42 |
| OPM % | 13.97% | 15.21% | 13.92% | -9.90% | 5.90% | 14.59% | 14.63% | 4.72% | 12.42% | 14.56% | 14.77% |
| Other Income | 1.25 | 2.23 | 0.18 | 14.41 | 5.52 | 1.68 | 4.50 | 5.05 | 1.24 | 2.06 | 1.44 |
| Interest | 4.18 | 5.03 | 6.58 | 6.95 | 5.31 | 3.49 | 4.17 | 5.78 | 6.46 | 6.16 | 6.22 |
| Depreciation | 4.33 | 4.78 | 5.74 | 6.13 | 6.11 | 6.31 | 7.01 | 6.09 | 6.35 | 6.44 | 6.24 |
| Profit before tax | 7.89 | 6.31 | -0.88 | -5.60 | -0.55 | 9.26 | 9.49 | -2.56 | -1.21 | 2.23 | 1.40 |
| Tax % | 36.25% | 28.68% | -20.45% | -11.25% | 16.36% | 30.67% | 29.50% | -30.08% | 16.53% | -79.37% | |
| Net Profit | 5.03 | 4.49 | -0.69 | -4.96 | -0.64 | 6.42 | 6.68 | -1.79 | -1.42 | 4.01 | 3.57 |
| EPS in Rs | 4.91 | 4.38 | -0.67 | -4.84 | -0.62 | 6.26 | 6.51 | -1.75 | -1.38 | 3.91 | 3.49 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | -1% | -7% | -1% | ||
| Compounded Profit Growth | % | 55% | -15% | 1950% | ||
| Stock Price CAGR | -2% | 14% | 11% | -11% | ||
| Return on Equity | 3% | 5% | 1% | 6% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 |
| Reserves | 32.65 | 37.18 | 36.52 | 34.34 | 33.46 | 39.70 | 45.74 | 57.96 | 56.81 | 59.35 |
| Borrowings | 44.53 | 60.62 | 55.08 | 49.45 | 49.82 | 34.68 | 36.79 | 66.15 | 68.65 | 59.37 |
| Other Liabilities | 31.41 | 34.16 | 35.88 | 36.19 | 27.03 | 25.06 | 28.01 | 24.13 | 26.23 | 35.53 |
| Total Liabilities | 118.84 | 142.21 | 137.73 | 130.23 | 120.56 | 109.69 | 120.79 | 158.49 | 161.94 | 164.50 |
| Fixed Assets | 59.72 | 70.92 | 68.83 | 69.97 | 69.80 | 69.97 | 70.43 | 87.16 | 94.08 | 85.85 |
| CWIP | 0.12 | 0.19 | 2.47 | 0.01 | 0.01 | 1.75 | 0.01 | 5.66 | 0.09 | 1.77 |
| Investments | 0.00 | 0.10 | 0.11 | 0.11 | 1.07 | 1.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 59.00 | 71.00 | 66.32 | 60.14 | 49.68 | 36.94 | 50.35 | 65.67 | 67.77 | 76.88 |
| Total Assets | 118.84 | 142.21 | 137.73 | 130.23 | 120.56 | 109.69 | 120.79 | 158.49 | 161.94 | 164.50 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 10.79 | 5.48 | 14.73 | 4.31 | 16.99 | 22.51 | 7.47 | -15.40 | 11.52 | 22.15 |
| Cash from Investing Activity | -12.85 | -17.18 | -2.80 | -2.52 | -11.36 | -4.24 | -3.40 | -10.11 | -7.70 | -2.85 |
| Cash from Financing Activity | 2.23 | 11.02 | -11.63 | -1.56 | -6.42 | -18.56 | -3.75 | 25.00 | -3.87 | -19.26 |
| Net Cash Flow | 0.17 | -0.67 | 0.30 | 0.23 | -0.79 | -0.29 | 0.32 | -0.51 | -0.05 | 0.04 |
| Free Cash Flow | -2.15 | -10.13 | 9.22 | 3.63 | 10.28 | 13.49 | 3.99 | -25.58 | 2.52 | 18.60 |
| CFO/OP | 82% | 50% | 134% | -64% | 315% | 136% | 55% | -344% | 111% | 175% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 129.57 | 192.39 | 177.08 | 122.81 | 94.37 | 57.86 | 93.85 | 164.27 | 182.19 | 187.78 |
| Inventory Days | 76.09 | 101.63 | 213.19 | 322.80 | 117.09 | 83.25 | 105.15 | 110.57 | 171.70 | 208.60 |
| Days Payable | 138.91 | 180.29 | 294.23 | 292.81 | 109.16 | 65.01 | 114.04 | 47.85 | 86.82 | 177.88 |
| Cash Conversion Cycle | 66.75 | 113.73 | 96.04 | 152.81 | 102.30 | 76.09 | 84.96 | 226.99 | 267.07 | 218.51 |
| Working Capital Days | -11.68 | -16.43 | -50.91 | -63.65 | -53.49 | -25.91 | -4.33 | 6.35 | -2.54 | 21.60 |
| ROCE % | 11.60% | 5.43% | 1.65% | 5.12% | 14.25% | 15.30% | 2.98% | 3.96% | 6.43% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% |
| DIIs | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% |
| Public | 26.37% | 26.37% | 26.35% | 26.37% | 26.36% | 26.37% | 26.36% | 26.38% | 26.37% | 26.36% | 26.37% | 26.37% |
| No. of Shareholders | 7,081 | 7,010 | 6,858 | 6,594 | 6,507 | 6,550 | 6,541 | 6,475 | 6,430 | 6,399 | 6,364 | 6,310 |
Fundamentals
Market Cap₹ 69.7 Cr.
Current Price₹ 68.0
Stock P/E18.9
Book Value₹ 67.9
ROCE6.43 %
ROE6.01 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-1%
Compounded Profit Growth (TTM)1950%
Consolidated figures.
Valuation
Market capRs 72 Cr
Enterprise valueRs 129 Cr
P/E (TTM)20.14x
Price to book1.03x
Price to sales0.86x
EV / EBITDA9.30x
EV / EBIT16.92x
EV / sales1.53x
Price to cash flow3.25x
Earnings yield4.97%
P/E, 3-year average15.85x
P/B, 3-year average0.95x
P/E, 5-year average11.99x
P/B, 5-year average1.07x
Profitability
Operating margin (excl. other income)14.56%
Operating margin (incl. other income)16.91%
EBITDA margin16.49%
Pre-tax margin1.67%
Net profit margin4.25%
Net margin, latest quarter2.42%
ROE5.87%
ROCE6.34%
ROA2.46%
ROE, 3-year average0.30%
ROCE, 3-year average4.35%
ROA, 3-year average0.10%
ROE, 5-year average5.44%
ROCE, 5-year average8.55%
ROA, 5-year average2.33%
ROIC (approx.)10.79%
Tax rate-79.37%
Other income / net worth2.96%
Growth
Sales growth (latest year)5.15%
Sales CAGR, 3 years-7.40%
Sales CAGR, 5 years-0.65%
Profit CAGR, 3 years-15.64%
Sales growth QoQ-3.70%
Profit growth QoQ-69.74%
Sales growth YoY (latest quarter)-16.12%
Profit growth YoY (latest quarter)-49.45%
Per share
EPS (TTM)Rs 3.48
EPS (latest year)Rs 3.91
EPS (latest quarter)Rs 0.45
EPS, 3-year averageRs 0.26
EPS, 5-year averageRs 2.71
Book value per shareRs 67.87
Sales per shareRs 81.98
Cash flow per shareRs 21.60
Free cash flow per shareRs 18.14
Efficiency
Asset turnover0.53x
Fixed asset turnover1.02x
Inventory turnover2.54x
Inventory days144 days
Debtor days188 days
Debtors turnover1.94x
Creditor days178 days
Cash conversion cycle219 days
Working capital days22 days
Leverage
Total debtRs 59 Cr
Cash and bankRs 2 Cr
Net debtRs 57 Cr
Debt to equity0.85x
Net debt / EBITDA4.12x
Interest coverage1.23x
Owners' fund to total sources42.31%
Debt to assets36.09%
Cash flow
Cash from Operating Activity (latest year)Rs 22 Cr
Cash from Investing Activity (latest year)Rs -3 Cr
Cash from Financing Activity (latest year)Rs -19 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs 19 Cr
FCFE (approx.: FCF + change in debt)Rs 9 Cr
Cash from ops / profit, 5 years3.47x
Sales to cash flow3.96x
Statement figures
Net sales (TTM)Rs 84 Cr
Net sales (latest year)Rs 88 Cr
Sales (latest quarter)Rs 19 Cr
Operating profit excl. other income (latest year)Rs 13 Cr
Operating profit (latest quarter)Rs 3 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs 14 Cr
PBDT (TTM)Rs 8 Cr
Profit before tax (TTM)Rs 1 Cr
Tax (latest year)Rs -2 Cr
Net profit (TTM)Rs 4 Cr
Net profit (latest year)Rs 4 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 6 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 6 Cr
Cost of goods sold (latest year)Rs 48 Cr
Total expenditure (latest year)Rs 75 Cr
Total income (latest year)Rs 90 Cr
Share capitalRs 10 Cr
ReservesRs 59 Cr
Shareholders' fundsRs 70 Cr
Total assetsRs 164 Cr
Net blockRs 86 Cr
Capital work in progressRs 2 Cr
ReceivablesRs 45 Cr
InventoryRs 19 Cr
Other liabilitiesRs 36 Cr
Shares outstanding (crore)1.03
Ownership
Promoter holding73.53% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | SUNLOC | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -2.6% | -2.8% | +0.1 pts |
| 1 month | -13.2% | -6.8% | -6.4 pts |
Red flags
F-score 8 of 8| explain | Low interest cover Interest cover 1.4x in 2026 |
| look | Profit leans on other income Other income was 92% of pre-tax profit in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹19 Cr -16.1% vs Jun 2025.
Net profit ₹0 Cr -49.5%.
Against our estimate for Jun 2026: sales -16.0%, profit -50.8% miss. Our estimate for Sep 2026: sales Rs 21 Cr, profit Rs 1 Cr (how).
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Less than 100 unique PAN traded in previous 30 days
Quick answers
What is the market cap of Sunil Healthcare Ltd?
Sunil Healthcare Ltd (SUNLOC) has a market capitalisation of Rs 69.7 Cr. at the 2026-10-01 close.
What is the P/E ratio of Sunil Healthcare Ltd?
Sunil Healthcare Ltd trades at a P/E of 18.9 on trailing twelve-month profit, at the 2026-10-01 close.
What were Sunil Healthcare Ltd's latest quarterly results?
In the Jun 2026 quarter, Sunil Healthcare Ltd sales was Rs 19 Cr (-16.1% vs Jun 2025) and net profit was Rs 0 Cr.
What is the 52-week high and low of Sunil Healthcare Ltd?
The 52-week high is Rs 82.00 and the 52-week low is Rs 67.50.